CIK 0001818794
- Large accelerated filer
Dyne Therapeutics, Inc.
Sign in to watch- Ticker
- DYN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 364883909
- Phone
- +1 781-786-8230
- Business address
- 1560 TRAPELO ROAD, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $40,000
- in 1 filing
- Open-market sales, last 90 days
- $421,679
- in 7 filings, $422K under 10b5-1 plans
Net −$381,679. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-09-21 | MPM BIOVENTURES 2018, L.P. 10% owner | Conversion | +91,081 | 91,081 | ||
| 2020-09-21 | MPM BIOVENTURES 2018, L.P. 10% owner | Conversion · Series A Preferred Stock | −13,980,992 | 0 | ||
| 2020-09-21 | MPM BIOVENTURES 2018, L.P. 10% owner | Conversion · Series A Preferred Stock | −743,076 | 0 | ||
| 2020-09-21 | MPM BIOVENTURES 2018, L.P. 10% owner | Conversion · Series A Preferred Stock | −275,932 | 0 | ||
| 2020-09-21 | MPM BIOVENTURES 2018, L.P. 10% owner | Conversion · Series B Preferred Stock | −1,326,313 | 0 | ||
| 2020-09-21 | MPM BIOVENTURES 2018, L.P. 10% owner | Conversion · Series B Preferred Stock | −70,492 | 0 | ||
| 2020-09-21 | MPM BIOVENTURES 2018, L.P. 10% owner | Conversion · Series B Preferred Stock | −26,176 | 0 | ||
| 2020-09-21 | VV Manager II, LLC 10% owner | Conversion | +2,087,130 | 2,087,130 | ||
| 2020-09-21 | VV Manager II, LLC 10% owner | Purchase | +792,995 | $19.00 | $15.1M | 2,880,125 |
| 2020-09-21 | VV Manager II, LLC 10% owner | Conversion | +57,916 | 57,916 | ||
| 2020-09-21 | VV Manager II, LLC 10% owner | Purchase | +22,005 | $19.00 | $418K | 79,921 |
| 2020-09-21 | VV Manager II, LLC 10% owner | Conversion · Series B Preferred Stock | −6,922,803 | 0 | ||
| 2020-09-21 | VV Manager II, LLC 10% owner | Conversion · Series B Preferred Stock | −192,102 | 0 | ||
| 2020-09-21 | Lubner David Charles Director | Conversion | +53,625 | 53,625 | ||
| 2020-09-21 | Lubner David Charles Director | Conversion · Series B Preferred Stock | −177,872 | 0 | ||
| 2020-09-21 | Logos Global Management LP 10% owner | Conversion | +804,392 | 804,392 | ||
| 2020-09-21 | Logos Global Management LP 10% owner | Purchase | +700,000 | $19.00 | $13.3M | 1,504,392 |
| 2020-09-21 | Logos Global Management LP 10% owner | Conversion · Series B Preferred Stock | −2,668,089 | 0 | ||
| 2020-09-21 | Forbion Capital Fund IV Cooperatief U.A. 10% owner | Conversion | +6,131,079 | 6,131,079 | ||
| 2020-09-21 | Forbion Capital Fund IV Cooperatief U.A. 10% owner | Conversion · Series A Preferred Stock | −15,000,000 | 0 |
Page 38 of 41 · 818 trades